EGFR and non-small cell lung carcinoma: EGFR mutations associated with NSCLC mainly comprise exons 18 to 21, with a deletion in exon 19 and an L858R mutation in exon 21 (EGFR-sensitizing mutations) accounting for approximately 90% of them [7, 8].